Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis. by Pazianas, M, Abrahamsen, B

Safety of bisphosphonates. by Pazianas, M, Abrahamsen, B

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications by Abrahamsen, B, Prieto-Alhambra, D

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted. by Abrahamsen, B, Pazianas, M, Russell, G

Safety issues with bisphosphonate therapy for osteoporosis. by Suresh, E, Pazianas, M, Abrahamsen, B

Eliminating the need for fasting with oral administration of bisphosphonates by Pazianas M, Abrahamsen B, Ferrari S, Russell RGG

Get full text

Eliminating the need for fasting with oral administration of bisphosphonates. by Pazianas, M, Abrahamsen, B, Ferrari, S, Russell, R

Epidemiological Factors Associated with Prescription of Opioids for Chronic Non-Cancer Pain in Adults: A Country-Wide, Registry-Based Study in Denmark Spans 2004–2018 by Hansen CA, Ernst MT, Smith CD, Abrahamsen B

Get full text

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan... by Pazianas, M, Abrahamsen, B, Wang, Y, Russell, G

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including ov... by Eiken, P, Prieto-Alhambra, D, Eastell, R, Abrahamsen, B

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment by Abrahamsen, B, Eiken, P, Prieto-Alhambra, D, Eastell, R

Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study by Prieto Alhambra, D, Abrahamsen, B, Eiken, P, Eastell, R

Excess mortality following hip fracture: a systematic epidemiological review. by Abrahamsen, B, van Staa, T, Ariely, R, Olson, M, Cooper, C

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study. by Pazianas, M, Abrahamsen, B, Eiken, P, Eastell, R, Russell, R

Bisphosphonates and colon cancer: reply. by Pazianas, M, Abrahamsen, B, Eiken, P, Eastell, R, Russell, R

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database. by Pazianas, M, Clark, E, Eiken, P, Brixen, K, Abrahamsen, B

Bisphosphonates and colon cancer: Reply by Pazianas, M, Abrahamsen, B, Eiken, P, Eastell, R, Russell, R

Esophageal and gastric cancer incidence and mortality in alendronate users. by Abrahamsen, B, Pazianas, M, Eiken, P, Russell, R, Eastell, R

The risk of oesophageal and gastric cancer incidence and mortality in alendronate users: National cohort study by Abrahamsen, B, Pazianas, M, Eiken, P, Russell, R, Eastell, R

Prevalence and incidence of clinically diagnosed knee, hip and hand osteoarthritis in women with polycystic ovary syndrome: A national register-based study by Sanchez-Santos, MT, Rubin, KH, Glintborg, D, Andersen, MS, Kluzek, WS, Abrahamsen, B